MAP2K1 and malignant peripheral nerve sheath tumor: Using gene expression profiling, our lab has identified the BMP2-SMAD1/5/8 signaling pathway as an NF1-dependent regulator of motility and invasiveness in MPNST cell lines, independent of the RAS-MEK1/2 signaling pathway [24].